INPP5D and neoplasm: Thus a potential use of SHIP1 selective inhibitors in epithelial cancers that lack it expression could be to impair homing of metastatic cells by tumor niche cells and in doing so increase the life expectation of stage 4 metastatic cancer patients [140].